Showing results (31-40 of 1,051) with videos related to
Sort By:
Pageof 106
Journal of Clinical Medicine|October 28, 2023
The Renal Composite Benefit of Sodium Glucose Co-Transporter 2 Inhibitors Should Ideally Be Assessed Based on a Standardised Definition: A Meta-Analysis of Randomised Controlled TrialsSamit Ghosal, Shamita Ghosal, Anuradha GhosalDiabetes & Metabolic Syndrome|May 20, 2020
Impact of complete lockdown on total infection and death rates: A hierarchical cluster analysisSamit Ghosal, Rahul Bhattacharyya, Milan MajumderDiabetes & Metabolic Syndrome|November 17, 2012
Quantitative vibration perception threshold in assessing diabetic neuropathy: is the cut-off value lower for Indian subjects? [Q-VADIS Study]Samit Ghosal, Jeff Stephens, Aninda MukherjeeESC Heart Failure|January 27, 2023
Heterogeneity in cardiovascular death or hospitalization for heart failure benefits with flozins is linked to weightSamit Ghosal, Binayak Sinha, Rik MukherjeeDiabetes & Metabolic Syndrome|August 7, 2020
"Compliance of the Indian National Task Force guidelines for COVID-19 recommendation by Indian doctors - A survey"Kalyan Kumar Gangopadhyay, Binayak Sinha, Samit GhosalScientific Reports|July 9, 2025
MISHTI study evaluating hepatic fibrosis in type 2 diabetes patients in IndiaDebasis Datta, Krishna G Seshadri, Samit GhosalDiabetes & Metabolic Syndrome|January 30, 2016
Insulin glargine versus insulin degludec in patients failing on oral therapy in type 2 diabetes: A retrospective real world comparative data from IndiaSamit Ghosal, Binayak Sinha, Kalyan Kumar GangopadhyayDiabetes, Metabolic Syndrome and Obesity : Targets and Therapy|August 2, 2014
Is insulin degludec a more effective treatment for patients using high doses of insulin glargine but not attaining euglycemia? Some case reports from IndiaBinayak Sinha, Kalyan Kumar Gangopadhyay, Samit GhosalDiabetes & Metabolic Syndrome|April 17, 2020
Linear Regression Analysis to predict the number of deaths in India due to SARS-CoV-2 at 6 weeks from day 0 (100 cases - March 14th 2020)Samit Ghosal, Sumit Sengupta, Milan Majumder, et al.Indian Heart Journal|June 15, 2020
Quantitative measure of asymptomatic cardiovascular disease risk in Type 2 diabetes: Evidence from Indian outpatient settingSamit Ghosal, Binayak Sinha, Jignesh Ved, et al.Pageof 106